1 / 2

Why wasn t a beta-blocker tested as first-line therapy

Reasons for no beta-blocker arm . Feasibility considerations allowed only 3-4 arms--traditional drug(s), ACEI, CCB, 1?Traditional drug choices considereddiuretic, beta-blocker, or either/both.Most hypertension trials used diuretics.Pooled results of 3 older diuretic vs. beta-blocker trials show

kiral
Download Presentation

Why wasn t a beta-blocker tested as first-line therapy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Why wasn’t a beta-blocker tested as first-line therapy?

    2. Reasons for no beta-blocker arm Feasibility considerations allowed only 3-4 arms--traditional drug(s), ACEI, CCB, +1? Traditional drug choices considered—diuretic, beta-blocker, or either/both. Most hypertension trials used diuretics. Pooled results of 3 older diuretic vs. beta-blocker trials showed no CVD differences. (Collins et al. Lancet 1990;335:827-38)

    3. Reasons for no beta-blocker arm (continued) Concerns about beta-blockers in patients with diabetes (oversampled in ALLHAT), although UKPDS results (atenolol vs captopril) subsequently lessened concerns (BMJ 1998;317:713-720). Pooled analyses of 18 trials ?low-dose diuretics but not beta-blockers prevent first CHD events (Psaty et al. JAMA 1997;277:739-45).

More Related